Related Experiment Video
Updated: May 24, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Atherosclerosis as an inflammatory disease
Antonino Tuttolomondo1, Domenico Di Raimondo, Rosaria Pecoraro
1Dipartimento Biomedico di Medicina Interna e Specialistica Università degli Studi di Palermo, Italy. bruno.tuttolomondo@unipa.it
Insights
Atherosclerosis is a chronic inflammatory disease driven by immune responses. Understanding the role of CD40 ligand (CD40L) in immune cell interactions offers new therapeutic targets for atherosclerosis.
Area of Science:
- Cardiovascular Biology
- Immunology
- Inflammation Research
Background:
- Atherosclerosis is increasingly recognized as a chronic inflammatory disorder.
- Recent research highlights the critical role of chemokines and immune cell accumulation in disease pathogenesis.
- The CD40-CD40 ligand (CD40L) pathway is implicated in immune responses within atherosclerotic lesions.
Purpose of the Study:
- To elucidate the mechanisms of immune cell involvement in atherosclerosis.
- To investigate the function of CD40 and CD40L in activating atheroma-associated cells.
- To explore novel therapeutic strategies targeting the inflammatory aspects of atherosclerosis.
Main Methods:
- Review of recent studies on chemokines, leukocyte recruitment, and immune cell functions in atherosclerosis.
- Analysis of CD40 and CD40L expression in vascular endothelial cells, smooth muscle cells, and macrophages.
- Examination of the role of CD40L in promoting the expression of adhesion molecules, cytokines, and other pro-atherogenic factors.
Main Results:
- CD40 and CD40L are coexpressed by key cells in human atherosclerotic lesions.
- CD40L activation of atheroma-associated cells promotes the expression of adhesion molecules, cytokines, matrix metalloproteinases, and tissue factor.
- Innate and adaptive immune responses, involving macrophages and T-lymphocytes, are central to atherosclerosis progression.
Conclusions:
- Contact-dependent interaction between CD40 and CD40L stimulates atheroma-associated cells.
- Macrophages play a pivotal role in plaque instability and progression.
- Targeting the inflammatory component of atherosclerosis presents a promising therapeutic avenue.
Abstract:
In many ways, atherosclerosis is a chronic inflammatory disorder and this issue is confirmed by recent investigations of that have focused on inflammation, providing new insight into mechanisms of disease. Several recent studies have addressed the role of chemokines in leukocyte accumulation in atherosclerosis, extending our knowledge and understanding of the complex and cell type-specific functions of chemokines in atherosclerosis. Activated T-lymphocytes within the atherosclerotic vessel wall express the CD40 ligand surface molecule, known to play a major role in several immunological pathways. In addition to activated T-lymphocytes, functional CD40 and CD40L are coexpressed by human vascular endothelial cells, smooth muscle cells and human macrophages in vitro as well as in situ in human atherosclerotic lesions. Recent studies indicate that CD40L activates atheroma-associated cells by promoting the expression of molecules thought to be involved in atherosclerosis, such as adhesion molecules, cytokines, matrix metalloproteinases, and tissue factor. Atherosclerosis starts with an innate immune response involving the recruitment and activation of monocytes macrophages that respond to an excessive accumulation of modified lipids within the arterial wall, followed by an adaptive immune response involving antigen-specific T lymphocytes. Effector T cells recognize modified auto-antigens such as oxidized LDL and heat shock proteins (i.e. HSP-60) that are presented by antigen-presenting cells such as macrophages or dendritic cells. The accumulation of inflammatory cells within the arterial wall leads to local production of chemokines, interleukins and proteases that enhance the influx of monocytes and lymphocytes, thereby promoting the progression of atherosclerotic lesions Recent reports have helped explain some of these questions by pointing to a role of contact dependent interaction between CD40 and CD40 ligand (CD40L, renamed CD154) as a stimulus for atheroma-associated cells. Also Macrophages play important roles in the progression of atherosclerosis by exhibiting unique characteristics under the various stimuli, evolving the plaque instability, thrombus formation and remodeling. Macrophage recruitment by abnormal endothelium over developing atherosclerotic plaques, is aided by endothelial expression of adhesion molecules (ICAM-1, VCAM, ELAM). The knowledge of atherosclerosis as an inflammatory disease offers the opportunity to develop novel therapeutic strategies targeting the inflammatory component of the disease.
Related Concept Videos
Atherosclerosis I: Introduction
Inflammation
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease II: Pathophysiology
Atherosclerosis IV: Nursing Management
